Lung CancerChemotherapy for Non-Small Cell Lung Carcinoma |
Physician-developed and -monitored. Original Date of Publication: 15 Aug 1999
|
|
Original Source: http://www.oncologychannel.com/lungcancer/chemotherapy-non-small-cell-lung-carcinoma.shtml | |
|
Home » Lung Cancer » Chemotherapy for Non-Small Cell Lung Carcinoma | 
 |
Gemcitabine hydrochloride (Gemzar®) is a chemotherapeutic drug that has unique activity against many solid tumors, including non-small cell lung cancer (NSCLC). Combination therapy with gemcitabine, cisplatin (Platinol®), and vinorelbine tartrate (Navelbine®) has been found to be safe and very active in persons with advanced non-small cell lung cancer (NSCLC). Tumors in these patients often cannot be removed by surgery (are unresectable), and so the patient may not survive for even 1 year without therapy.
| OPTION 1: Combination chemotherapy with gemcitabine (Gemzar®), cisplatin (Platinol®), and vinorelbine tartrate (Navelbine®) |
The toxic side effects of combination chemotherapy are manageable in most patients. Side effects include neutropenia (reduced number of granular white blood cells) and thrombocytopenia (reduced number of blood-clotting platelets).
Another treatment option for NSCLC patients with advanced disease is alternating chemo-radiotherapy (e.g., cisplatin and etoposide, followed by radiotherapy):
| OPTION 2: Combination chemotherapy with etoposide (VP-16, VePesid®) and cisplatin (Platinol®), also called "EC" followed by 60 Gy chest radiation therapy plus surgical resection of tumor or pneumonectomy (lung removal) in cases of operable tumor |
The toxic side effects of this program are leukopenia (reduced number of white blood cells) and vomiting.
Chemotherapeutic programs alone have limited activity against non-small cell lung cancer; however, new "protective" drugs, cytotoxic (cell-killing) agents, and radiotherapy techniques—either alone or in combination—are promising.
For example, the cell-protecting compound amifostine (Ethyol; Alza Pharmaceuticals, Palo Alto, CA/US Bioscience, West Conshohocken, PA) is being tested for its defense of normal tissue against the toxic effects of chemotherapy and radiotherapy. This, or similar medication(s), may permit physicians to use higher doses of chemotherapeutic agents (e.g., cisplatin, carboplatin, paclitaxel), thereby improving therapeutic results, prognosis, and survival.
Lung Cancer, Chemotherapy for Non-Small Cell Lung Carcinoma reprinted with permission from oncologychannel.com
© 1998-2009 Healthcommunities.com, Inc. All Rights Reserved.
Lung Cancer (continued...)
Lung Cancer Resources
 | Join Our Lung Cancer Forum
Do you have a question, want to share medical advice, or just need to discuss your situation with someone else having a similar experience? The healthchannels forum is a resource for everyone to share and discuss their health and medical needs with others. |
|
|
 | Living with...Share your story
Do you have a personal health story that you would like to share with others? As a source of free patient education, our goal is to provide our users with trustworthy information and support from others. That's why we've started our "Living with..." sections. | ||
|
Our "Living With..." support pages are a place to share experiences about living with a certain condition, disease, disorder, or illness and for loved ones of those dealing with health-related issues. Many people, especially when newly diagnosed, find comfort in knowing that others are having a similar experience. | |||
 | Stay Updated
Sign up for our newsletter and receive important updates on the medical conditions that are most important to you. | ||
To quickly access health information from your website's browser,
| |||
email this
